MANNING ANTHONY M. (Chief Scientific Officer) sold 24.3% of their position (6.76K shares) of MOMENTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $203.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/15/2020ACC: 0001179110-20-007361
Officer· Chief Scientific Officer
Since Oct 2018
+23.24K
Net shares
Net buyer
$203.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
30K acquired · 6.76K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
—
Trade value
—
% of position
117.6%
6/11/2020
12.76K→27.76K
Common Stock
Direct
Shares
−6.76K
Price / share
$30.15
Trade value
$203.69K
% of position
24.3%
6/12/2020
27.76K→21K
Total
Net shares
+8.24K
Net value
-$203.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2020 | A · Award | +15K | — | — | 117.6% | 12.76K | 27.76K |
| Common Stock Direct | 6/12/2020 | S · Sale | −6.76K | $30.15 | $203.69K | 24.3% | 27.76K | 21K |
| Total | +8.24K | -$203.69K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
15K shares
Shares
+15K
Strike price
Held after
30K
Exercisable
—
6/11/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock15K shares | 6/11/2020 | A · Award | +15K | — | 30K |